跳至主要内容
临床试验/EUCTR2015-005151-27-ES
EUCTR2015-005151-27-ES进行中(未招募)1 期

Randomized prospective clinical trial to evaluate the rate of early recurrence in bladder cancer in non-muscle invasive between the chemohyperthermia (QH) with mitomycin-C prior to transurethral resection of bladder in ambulatory surgery program and post resection treatment with mitomycin C in normothermia.

Hospital Universitario de Canarias0 个研究点开始时间: 2016年3月18日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • More than 18 years
  • vesical tumor <3cm
  • multiple vesical tumors, in total <8 cm and <3cm each one
  • ASA less or equal than III
  • low or intermediate risk
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 83
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • - Known hipersensibility to MMC or excipients.
  • - Pregnant or lactancy
  • - Recent Transuretral resection (<2 years)
  • - Vesical in situ carcinoma suspected (Cis).
  • - Vesical tumor > 3 cm
  • - to have more than 8 tumors
  • - Severe cardiopathy
  • - Chronic renal insufficinecy
  • - Trombocitopenia ( <100.000 platets) ,coagulation disorders and bleeding tendency for other causes.

研究者

相似试验